ORMP — ORAMED PHARMACEUTICALS INC

Ownership history in RBF Capital, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which RBF Capital, LLC reported a position in ORAMED PHARMACEUTICALS INC (ORMP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q1)
Avg. % of fund
0.01%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 42,947 — 0% 0.01% $122K $2.66
2025 Q3 UNCHANGED 42,947 — 0% 0.01% $113K $2.46
2025 Q2 UNCHANGED 42,947 — 0% 0.00% $97K $2.10
2025 Q1 INITIATED 42,947 — — 0.01% $92K $2.00
% of Fund (quarterly)    ORMP price (monthly, adj. close)

Other funds also holding ORMP

As of 2025 Q4 — sorted by position size

BML Capital Management, LLC 3Y 7.8% SB Capital Management Inc 1.98% Murchinson Ltd. 3Y 0.61% Redwood Family Wealth LLC 0.06% BOOTHBAY FUND MANAGEMENT, LLC 3Y 7Y 0.03% Sage Capital Management, LLC 0.02% Glass Jacobson Investment Advisors llc 3Y 0.01% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.01% PRELUDE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% XTX Topco Ltd 3Y 0.0%
← Back to RBF Capital, LLC Holdings